1-(3,4-dichlorobenzyl)pyrrolidin-3-ol
|
- $225 - $500.8
- Product name: 1-(3,4-dichlorobenzyl)pyrrolidin-3-ol
- CAS: 415953-24-1
- MF: C11H13Cl2NO
- MW: 246.13
- EINECS:
- MDL Number:
- Synonyms:1-(3,4-dichlorobenzyl)pyrrolidin-3-ol;1-[(3,4-Dichlorophenyl)methyl]pyrrolidin-3-ol;3-Pyrrolidinol, 1-[(3,4-dichlorophenyl)methyl]-
4 prices
Selected condition：
Brand
- Alichem
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 500mg
- 1g
- ManufacturerAlichem
- Product number415953241
- Product description1-(3,4-Dichlorobenzyl)pyrrolidin-3-ol
- Packaging1g
- Price$472.77
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0226514
- Product description1-(3,4-DICHLORO-BENZYL)-PYRROLIDIN-3-OL 95.00%
- Packaging5MG
- Price$500.8
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM301154
- Product description1-(3,4-dichlorobenzyl)pyrrolidin-3-ol 95%
- Packaging500mg
- Price$225
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11126519
- Product description1-(3,4-Dichlorobenzyl)pyrrolidin-3-ol 95+%
- Packaging1g
- Price$459
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Alichem | 415953241 | 1-(3,4-Dichlorobenzyl)pyrrolidin-3-ol | 1g | $472.77 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0226514 | 1-(3,4-DICHLORO-BENZYL)-PYRROLIDIN-3-OL 95.00% | 5MG | $500.8 | 2021-12-16 | Buy |
| Chemenu | CM301154 | 1-(3,4-dichlorobenzyl)pyrrolidin-3-ol 95% | 500mg | $225 | 2021-12-16 | Buy |
| Crysdot | CD11126519 | 1-(3,4-Dichlorobenzyl)pyrrolidin-3-ol 95+% | 1g | $459 | 2021-12-16 | Buy |
Properties
Boiling point :352.1±42.0 °C(Predicted)
Density :1.375±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :14.77±0.20(Predicted)
Density :1.375±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :14.77±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|